Foxo1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
FOXO1 (Forkhead Box O1) is a transcription factor belonging to the Fox family of winged-helix DNA-binding proteins. It plays crucial roles in cellular stress response, metabolism, apoptosis, autophagy, and longevity. FOXO1 is particularly important in neuronal survival and is implicated in neurodegenerative diseases.
| Property |
Value |
| Symbol |
FOXO1 |
| Full Name |
Forkhead Box O1 |
| Chromosomal Location |
13q14.11 |
| NCBI Gene ID |
2308 |
| OMIM |
136351 |
| Ensembl ID |
ENSG00000150907 |
| UniProt ID |
Q12778 |
- FKHR (Forkhead in Rhabdomyosarcoma)
- FOXO1A
FOXO1 is a transcription factor that regulates gene expression by binding to specific DNA sequences (TTGTTTAC). It responds to various cellular signals including oxidative stress, nutrient deprivation, and growth factor withdrawal.
- Stress response - Activates genes involved in oxidative stress resistance
- Metabolic regulation - Controls gluconeogenesis, glycogen metabolism, and lipid metabolism
- Cell cycle regulation - Induces cell cycle arrest via p21 and p27
- Apoptosis - Promotes apoptosis under stress conditions
- Autophagy - Activates autophagy genes (ATG genes, LC3)
- Longevity - Associated with extended lifespan in model organisms
FOXO1 activity is regulated by post-translational modifications:
- Phosphorylation - AKT/PKB, ERK, IKK phosphorylate FOXO1, leading to nuclear export
- Acetylation - SIRT1 deacetylates FOXO1, enhancing its activity
- Ubiquitination - MDM2 and SKP2 mediate FOXO1 degradation
- FOXO1 activation promotes neuronal survival
- Aβ toxicity increases FOXO1 nuclear translocation
- Therapeutic targeting potential
- Related: Amyloid Cascade Pathway
- FOXO1 protects dopaminergic neurons
- α-Synuclein affects FOXO1 activity
- Potential therapeutic target
- Related: Alpha-Synuclein Aggregation Pathway
- Mutant huntingtin affects FOXO1 localization
- FOXO1 transcriptional activity impaired
- Therapeutic implications
¶ Stroke and Ischemia
- FOXO1 mediates ischemic preconditioning
- Protective in cerebral ischemia
- FOXO1 functions as tumor suppressor
- Deregulated in various cancers
FOXO1 is widely expressed:
- Brain - Neurons, astrocytes, microglia
- Liver - High expression in hepatocytes
- Muscle - Skeletal and cardiac muscle
- Adipose tissue - Preadipocytes and adipocytes
- Pancreas - β-cells
- Natural compounds (resveratrol, curcumin)
- SIRT1 activators
- AKT inhibitors
- AAV-mediated FOXO1 delivery
- CRISPR activation of FOXO1
- Balance between pro-survival and pro-apoptotic functions
- Tissue-specific delivery
- FOXO transcription factors in neuronal survival - Cell, 2007
- FOXO1 and metabolic disease - Nature Reviews Endocrinology, 2013
- FOXO1 in Alzheimer disease - Journal of Neuroscience, 2011
- SIRT1-FOXO1 axis in longevity - Cell, 2008
- FOXO3 Gene
- FOXO1 Protein
- SIRT1 Gene
- MAPK Signaling Pathway
- Autophagy Lysosomal Pathway
- Oxidative Stress Pathway
- Alzheimer Disease
- Parkinson Disease
- Huntington Disease
The study of Foxo1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Burgering BM, et al. (2008). FOXO transcription factors in neuronal survival. Cell.
[2] Kousteni S, et al. (2011). FOXO1 and metabolic disease. Nat Rev Endocrinol.
[3] Maiese K, et al. (2011). FOXO1 in Alzheimer disease. J Neurosci.
[4] Brunet A, et al. (2004). SIRT1-FOXO1 axis in longevity. Cell.
[5] Kops GJ, et al. (2002). FOXO1 in apoptosis. Nature.